Webster JA, Yogarajah M, Zahurak M, Symons H, et al. A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic Leuk Lymphoma 2021 Jul 21:1-11. doi: 10.1080/10428194.2021.1948029.
PMID: 34284701